Restoration of splenic noradrenergic nerve fibers and immune reactivity in old F344 rats: A comparison between L-deprenyl and L-desmethyldeprenyl

International Journal of Immunopharmacology

Volumn 22, Issue 7, 2000, Pages 523-536

  Thyagarajan, S ^a   Madden, K S ^b   Stevens, S Y ^b   Felten, D L ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Aging; Interferon ; L desmethylselegiline; Lymphocytes; Norepinephrine; Selegiline; Tyrosine hydroxylase

Indexed keywords

CD5 ANTIGEN; CONCANAVALIN A; DRUG METABOLITE; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 2; NORSELEGILINE; SELEGILINE; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL CELL; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL DENSITY; CONTROLLED STUDY; DOSE RESPONSE; ELECTROCHEMICAL DETECTION; ENANTIOMER; FLOW CYTOMETRY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOCHEMISTRY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MORPHOMETRICS; NERVE FIBER; NONHUMAN; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SPLEEN; T LYMPHOCYTE;

ADRENERGIC FIBERS; AGING; AMPHETAMINES; ANIMALS; MALE; NERVE REGENERATION; NOREPINEPHRINE; RATS; RATS, INBRED F344; SELEGILINE; SPLEEN;

EID: 0034237371     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(00)00016-3     Document Type: Article

References (34)

1. Abramchik G.V., Yermakova S.S., Kaliunov V.N., Tanina R.M., Tumilovich M.K. The immunomodulatory effect of nerve growth factor. J Neurosci Res. 19:1988;349-356.
2. Ansari K.S., Yu P.H., Kruck T.P.A., Tatton W.G. Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J Neurosci. 13:1993;4042-4053.
3. Birkmayer W., Knoll J., Riederer P., Youdim M.B.H. (-)Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease. Mod Probl Pharmacopsychiatry. 19:1983;170-176.
4. Bellinger D.L., Ackerman K.D., Felten S.Y., Felten D.L. A longitudinal study of age-related loss of noradrenergic nerves and lymphoid cells in the rat spleen. Exp Neurol. 116:1992;295-311.
5. Bellinger D.L., Felten S.Y., Ackerman K.D., Lorton D., Madden K.S., Felten D.L. Noradrenergic sympathetic innervation of lymphoid organs during development, aging, and in autoimmune disease. Amenta F. Aging of the autonomic nervous system. 1993;243-284 CRC Press, Boca Raton, Fl.
6. Borbe H.O., Niebch G., Nickel B. Kinetic evaluation of MAO-B-activity following oral administration of selegiline and desmethyl-selegiline in the rat. J Neural Transm Suppl. 32:1990;131-137.
7. Carrillo M.C., Kitani K., Kanai S., Sato Y., Miyasaka K., Ivy G.O. The effect of a long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer 344 rats. Biochem Pharmacol. 8:1994;1333-1338.
8. de la Cruz C.P., Revilla E., Steffen V., Rodriguez-Gomez J.A., Cano J., Machado A. Protection of the aged substantia nigra of the rat against oxidative damage by (-)-deprenyl. Br J Pharmacol. 117:1996;1756-1760.
9. Freire-Garabal M., Balboa J.L., Nunez M.J., Castano M.T., Llovo J.B., Fernandez-Rial J.C., Belmonte A. Effects of amphetamine on T-cell immune response in mice. Life Sci. 49:1991;PL107-PL112.
10. Freisleben H.J., Lehr F., Fuchs J. Lifespan of immunosuppressed NMRI-mice is increased by deprenyl. J Neural Transm (suppl.). 41:1994;231-236.
11. Heinonen E.H., Myllyla V., Sotaniemi K., Lamintausta R., Salonen J.S., Antilla M., Savijarvi M., Kotila M., Rinne U.K. Pharmacokinetics and metabolism of selegiline. Acta Neurol Scand. 126:1989;93-99.
12. Heinonen E.H., Antilla M.I., Lammintausta R.A.S. Pharmacokinetic aspects of L-deprenyl (selegiline) and its metabolites. Clin Pharmacol Ther. 56:1994;742-749.
13. Heinonen E.H., Anttila M.I., Karnani H.L., Nyman L.M., Vuorinen J.A., Pyykko K.A., Lammintausta R.A. Desmethylselegiline, a metabolite of selegiline, is an irreversible inhibitor of monoamine oxidase type B in humans. J. Clin. Pharmacol. 37:1997;602-609.
14. Knoll J. The striatal dopamine dependency of life span in male rats. Longevity study with (-)deprenyl. Mech. Ageing Dev. 46:1988;237-262.
15. Kushleika J., Checkoway H., Woods J.S., Moon J.D., Smith-Weller T., Franklin G.M., Swanson P.D. Selegiline and lymphocyte superoxide dismutase activities in Parkinson's disease. Ann Neurol. 39:1996;378-381.
16. Madden K.S., Moynihan J.A., Brenner G.J., Felten S.Y., Felten D.L., Livnat S. Sympathetic nervous system modulation of the immune system. Part III: alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J. Neuroimmunol. 49:1994;77-87.
17. Madden K.S., Sanders V.M., Felten D.L. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol. 35:1995;417-448.
18. Mosmann T.R., Schumacher J.H., Street N.F., Budd R., O'Garra A., Fong T.A., Bond M.W., Moore K.W., Sher A., Fiorentino D.F. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol Rev. 123:1991;209-229.
19. Mytilineou C., Radcliffe P.M., Olanow C.W. L-(-)-desmethylselegiline, a metabolite of selegiline [L-(-)-deprenyl], protects mesencephalic dopamine neurons from excitotoxicity in vitro. J Neurochem. 68:1997;434-436.
20. Mytilineou C., Leonardi E.K., Radcliffe P., Heinonen E.H., Han S.K., Werner P., Cohen G., Olanow C.W. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. J Pharmacol Exp Ther. 284:1998;700-706.
21. Nunez-Iglesias M.J., Castro-Bolano C., Losada C., Pereiro-Raposo M.D., Riveiro P., Sanchez-Sebio P., Mayan-Santos J.M., Rey-Mendez M., Freire-Garabal M. Effects of amphetamine on cell mediated immune response in mice. Life Sci. 58:1996;PL29-PL33.
22. Renoux G., Biziere K., Renoux M., Steinberg R., Kan J.P., Guillaumin J.M. Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice. Life Sci. 44:1989;771-777.
23. Santambrogio L., Benedetti M., Chao M.V., Muzaffar R., Kulig K., Gabellini N., Hochwald G. Nerve growth factor production by lymphocytes. J. Immunol. 153:1994;4488-4495.
24. Simpson L.L. Evidence that deprenyl, a type B monoamine oxidase inhibitor is an indirectly acting sympathomimetic amine. Biochem Pharmacol. 27:1978;1591-1595.
25. Swerdlow N.R., Hauger R., Irwin M., Koob G.F., Britton K.T., Pulvirenti L. Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication. Neuropsychopharmacology. 5:1991;23-31.
26. Tatton W.G., Chalmers-Redman R.M. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration. Neurology. 47:1996;S171-183.
27. ThyagaRajan S., Felten S.Y., Felten D.L. Restoration of sympathetic noradrenergic nerve fibers in the spleen by low doses of l-deprenyl treatment in young sympathectomized and old Fischer 344 rats. J. Neuroimmunol. 81:1998;144-157.
28. ThyagaRajan S., Madden K.S., Kalvass J.C., Dimitrova S., Felten S.Y., Felten D.L. L- deprenyl-induced increase in IL-2 and NK cell activity accompanies restoration of noradrenergic nerve fibers in the spleens of old F344 rats. J. Neuroimmunol. 92:1998;9-21.
29. ThyagaRajan S., Felten S.Y., Felten D.L. Anti-tumor effect of L-deprenyl in rats with carcinogen-induced mammary tumors. Cancer Lett. 123:1998;177-183.
30. ThyagaRajan S., Madden K.S., Stevens S.Y., Felten D.L. Effects of L-deprenyl treatment on noradrenergic innervation and immune reactivity in lymphoid organs of young F344 rats. J. Neuroimmunol. 96:1999;57-65.
31. ThyagaRajan S., Quadri S.K. L-deprenyl stimulates the release of catecholamines in the rat medial basal hypothalamus in vivo. Neurosci Lett. 270:1999;79-82.
32. ThyagaRajan S., Madden K.S., Stevens S.Y., Felten D.L. Region-specific alterations in the concentrations of catecholamines and indoleamines in the brains of young and old F344 rats after L-deprenyl treatment. Brain Res. Bull. 48:1999;513-520.
33. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376.
34. Yoshida T., Yamada Y., Yamamoto T., Kuroiwa Y. Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency. Xenobiotica. 16:1986;129-136.